Brazil Approves New Diabetes Drug for 16 Million Patients

Brazil just approved a new semaglutide treatment that could help 16.

5 million people with diabetes access life-changing medication.

The affordable option launches later this year, with the potential to reach millions who currently go undiagnosed or untreated.